{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:15:35Z","timestamp":1792178135248,"version":"4.4.0"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:p>\n                    Curcumin, the key bioactive phytochemical present in turmeric (\n                    <jats:italic toggle=\"yes\">Curcuma longa<\/jats:italic>\n                    L.), is the most studied natural compound in cancer. Preclinical studies (\n                    <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                    and\n                    <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                    ) and clinical trials have demonstrated curcumin's effectiveness as an anti-inflammatory agent. The existing evidence supports that curcumin inhibits the proliferation of many types of cancer cells and can play an important role in cancer therapy. This study analyses the existing evidence in the literature on finalized clinical trials (2010\u20132020) related to the effect of curcumin and turmeric-derived products that focused on different types of cancers, such as chronic myeloid leukemia, multiple myeloma, prostate, colorectal and pancreatic cancer as well as cancer therapy-related complications, including oral mucositis and radiation dermatitis. Original English language articles and clinical trials published between 2010 and 2020 were searched using mainstream scholarly databases, such as PubMed, ScienceDirect, Google Scholar, and ClinicalTrials.gov. The keywords, such as \u201ccurcumin,\u201d \u201cturmeric,\u201d \u201ccancer,\u201d \u201canti-inflammatory,\u201d and \u201cclinical trials,\u201d were used in various combinations. A total of 21 clinical trials were selected, reviewed, and included in this study. Sixteen out of 21 clinical trials were associated with the effectiveness of curcumin or turmeric on various types of cancer, and the other five clinical trials were related to the evaluation of the efficacy of curcumin or turmeric in relieving the side effects of cancer chemotherapy and radiotherapy. The emerging data from the clinical trials confirm that curcumin has the potential for cancer prevention and intervention. However, it is not yet clear whether long-term curcumin supplementation has similar benefits.\n                  <\/jats:p>","DOI":"10.4103\/jcrt.jcrt_1017_20","type":"journal-article","created":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T10:31:54Z","timestamp":1674815514000},"page":"19-26","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":62,"title":["The golden spice curcumin in cancer: A perspective on finalized clinical trials during the last 10 years"],"prefix":"10.4103","volume":"18","author":[{"given":"Ay\u015fe K\u00fcbra","family":"Karabo\u011fa Arslan","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Faculty of Pharmacy, Erciyes University, Kayseri, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebru","family":"Uzunhisarc\u0131kl\u0131","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Pharmacy, Erciyes University, Kayseri, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00fckerrem Bet\u00fcl","family":"Yerer","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Pharmacy, Erciyes University, Kayseri, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupam","family":"Bishayee","sequence":"additional","affiliation":[{"name":"Lake Erie College of Osteopathic Medicine, Bradenton, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,3,30]]},"reference":[{"key":"R3-20250510","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/biof.1079","article-title":"Curcumin, a component of turmeric: From farm to pharmacy","volume":"39","author":"Gupta","year":"2013","journal-title":"Biofactors"},{"key":"R7-20250510","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1002\/mnfr.201100741","article-title":"Multitargeting by turmeric, the golden spice: From kitchen to clinic","volume":"57","author":"Gupta","year":"2013","journal-title":"Mol Nutr Food Res"},{"key":"R8-20250510","first-page":"350","article-title":"Curcumin for monoclonal gammopathies","volume":"84","author":"Vermorken","year":"2012","journal-title":"What can we hope for, what should we fear? Crit Rev Oncol Hematol"},{"key":"R9-20250510","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jtcme.2016.05.005","article-title":"Biological activities of curcuminoids, other biomolecules from turmeric and their derivatives \u2013 A review","volume":"7","author":"Amalraj","year":"2017","journal-title":"J Tradit Complement Med"},{"key":"R10-20250510","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.cgh.2015.02.019","article-title":"Curcumin in combination with mesalamine induces remission in patients with mild-to-moderate ulcerative colitis in a randomized controlled trial","volume":"13","author":"Lang","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R11-20250510","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/JCP.0000000000000508","article-title":"Safety, tolerance, and enhanced efficacy of a bioavailable formulation of curcumin with fenugreek dietary fiber on occupational stress a randomized, double-blind, placebo-controlled pilot study","volume":"36","author":"Sudheeran","year":"2016","journal-title":"J Clin Psychopharmacol"},{"key":"R12-20250510","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.biocel.2008.06.010","article-title":"Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases","volume":"41","author":"Aggarwal","year":"2009","journal-title":"Int J Biochem Cell Biol"},{"key":"R13-20250510","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuint.2015.10.011","article-title":"Novel promising therapeutics against chronic neuroinflammation and neurodegeneration in Alzheimer's disease","volume":"95","author":"Venigalla","year":"2016","journal-title":"Neurochem Int"},{"key":"R14-20250510","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jtcme.2016.08.002","article-title":"Curcumin: An age-old anti-inflammatory and anti-neoplastic agent","volume":"7","author":"Fadus","year":"2017","journal-title":"J Tradit Complement Med"},{"key":"R15-20250510","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.bcp.2007.08.016","article-title":"Curcumin as \u201cCurecumin\u201d: From kitchen to clinic","volume":"75","author":"Goel","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"R16-20250510","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s00018-008-7452-4","article-title":"Curcumin: From ancient medicine to current clinical trials","volume":"65","author":"Hatcher","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"R17-20250510","doi-asserted-by":"crossref","first-page":"13017","DOI":"10.1007\/s13277-016-5183-y","article-title":"Molecular targets of curcumin for cancer therapy: An updated review","volume":"37","author":"Kasi","year":"2016","journal-title":"Tumour Biol"},{"key":"R18-20250510","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.2174\/138945012804545632","article-title":"Chemopreventive and chemotherapeutic potential of curcumin in breast cancer","volume":"13","author":"Sinha","year":"2012","journal-title":"Curr Drug Targets"},{"key":"R19-20250510","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2174\/138920112798868791","article-title":"Curcumin and liver cancer: A review","volume":"13","author":"Darvesh","year":"2012","journal-title":"Curr Pharm Biotechnol"},{"key":"R20-20250510","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1080\/01635581.2018.1412485","article-title":"Curcumin and melanoma: From chemistry to medicine","volume":"70","author":"Nabavi","year":"2018","journal-title":"Nutr Cancer"},{"key":"R21-20250510","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s11523-014-0321-1","article-title":"Curcumin and lung cancer \u2013 A review","volume":"9","author":"Mehta","year":"2014","journal-title":"Target Oncol"},{"key":"R22-20250510","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1159\/000491886","article-title":"Liposomal curcumin targeting endometrial cancer through the NF-\u03baB pathway","volume":"48","author":"Xu","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"R23-20250510","doi-asserted-by":"crossref","first-page":"1036360","DOI":"10.1155\/2020\/1036360","article-title":"Curcumin, alone or in combination with aminoguanidine, increases antioxidant defenses and glycation product detoxification in streptozotocin-diabetic rats: A therapeutic strategy to mitigate glycoxidative stress","volume":"2020","author":"Lima","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"R24-20250510","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.nutres.2020.03.002","article-title":"A systemic review on the antioxidant and anti-inflammatory effects of resveratrol, curcumin, and dietary nitric oxide supplementation on human cardiovascular health","volume":"78","author":"Banez","year":"2020","journal-title":"Nutr Res"},{"key":"R25-20250510","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/jcp.25756","article-title":"Curcumin as a potential candidate for treating hyperlipidemia: A review of cellular and metabolic mechanisms","volume":"233","author":"Panahi","year":"2018","journal-title":"J Cell Physiol"},{"key":"R26-20250510","first-page":"2895","article-title":"Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions","volume":"21","author":"Cheng","year":"2001","journal-title":"Anticancer Res"},{"key":"R27-20250510","doi-asserted-by":"crossref","first-page":"283634","DOI":"10.1155\/2015\/283634","article-title":"Oral curcumin (Meriva) is effective as an adjuvant treatment and is able to reduce IL-22 serum levels in patients with psoriasis vulgaris","volume":"2015","author":"Antiga","year":"2015","journal-title":"Biomed Res Int"},{"key":"R28-20250510","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s00280-013-2151-8","article-title":"A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin\u00ae) in cancer patients","volume":"71","author":"Kanai","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"key":"R29-20250510","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1002\/ptr.5201","article-title":"Evaluation of the effect of curcumin capsules on glyburide therapy in patients with type-2 diabetes mellitus","volume":"28","author":"Neerati","year":"2014","journal-title":"Phytother Res"},{"key":"R30-20250510","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"R31-20250510","first-page":"1","article-title":"Dose escalation of a curcuminoid formulation","volume":"6","author":"Lao","year":"2006","journal-title":"BMC Comp Altern Med"},{"key":"R32-20250510","doi-asserted-by":"crossref","first-page":"6847","DOI":"10.1158\/1078-0432.CCR-04-0744","article-title":"Phase I clinical trial of oral curcumin: Biomarkers of systemic activity and compliance","volume":"10","author":"Sharma","year":"2004","journal-title":"Clin Cancer Res"},{"key":"R33-20250510","first-page":"9384","article-title":"Therapeutic applications of curcumin for patients with pancreatic cancer","volume":"20","author":"Kanai","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R34-20250510","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/ptr.5149","article-title":"Adjuvant therapy with bioavailability-boosted curcuminoids suppresses systemic inflammation and improves quality of life in patients with solid tumors: A randomized double-blind placebo-controlled trial","volume":"28","author":"Panahi","year":"2014","journal-title":"Phytother Res"},{"key":"R35-20250510","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1177\/1078155211416530","article-title":"Effect of imatinib therapy with and without turmeric powder on nitric oxide levels in chronic myeloid leukemia","volume":"18","author":"Ghalaut","year":"2012","journal-title":"J Oncol Pharm Pract"},{"key":"R36-20250510","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/ajh.23159","article-title":"Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: A randomized, double-blind placebo-controlled cross-over 4g study and an open-label 8g extension study","volume":"87","author":"Golombick","year":"2012","journal-title":"Am J Hematol"},{"key":"R37-20250510","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000441148","article-title":"The new combination docetaxel, prednisone and curcumin in patients with castration-resistant prostate cancer: A pilot phase II study","volume":"90","author":"Mahammedi","year":"2016","journal-title":"Oncology"},{"key":"R40-20250510","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3389\/fnut.2018.00138","article-title":"A Phase 2 study to assess the immunomodulatory capacity of a lecithin-based delivery system of curcumin in endometrial cancer","volume":"5","author":"Tuyaerts","year":"2018","journal-title":"Front Nutr"},{"key":"R45-20250510","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1080\/01635581.2015.1073754","article-title":"Antioxidant and anticoagulant status were improved by personalized dietary intervention based on biochemical and clinical parameters in cancer patients","volume":"67","author":"Lee","year":"2015","journal-title":"Nutr Cancer"},{"key":"R46-20250510","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/1534735413503549","article-title":"The Indian spice turmeric delays and mitigates radiation-induced oral mucositis in patients undergoing treatment for head and neck cancer: An investigational study","volume":"13","author":"Rao","year":"2014","journal-title":"Integr Cancer Ther"},{"key":"R47-20250510","first-page":"258","article-title":"Effectiveness of Indian turmeric powder with honey as complementary therapy on oral mucositis: A nursing perspective among cancer patients in Mysore","volume":"105","author":"Francis","year":"2014","journal-title":"Nurse J India"},{"key":"R48-20250510","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ptr.5014","article-title":"A controlled study of a lecithinized delivery system of curcumin (Meriva\u00ae) to alleviate the adverse effects of cancer treatment","volume":"28","author":"Belcaro","year":"2014","journal-title":"Phytother Res"},{"key":"R49-20250510","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/01635581.2016.1115527","article-title":"Effect of curcumin supplementation during radiotherapy on oxidative status of patients with prostate cancer: A double blinded, randomized, placebo-controlled study","volume":"68","author":"Hejazi","year":"2016","journal-title":"Nutr Cancer"},{"key":"R51-20250510","doi-asserted-by":"crossref","first-page":"20130490","DOI":"10.1259\/bjr.20130490","article-title":"Topical application of a sandal wood oil and turmeric based cream prevents radiodermatitis in head and neck cancer patients undergoing external beam radiotherapy: A pilot study","volume":"87","author":"Palatty","year":"2014","journal-title":"Br J Radiol"},{"key":"R53-20250510","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1667\/RR3255.1","article-title":"Curcumin for radiation dermatitis: A randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients","volume":"180","author":"Ryan","year":"2013","journal-title":"Radiat Res"},{"key":"R54-20250510","first-page":"21","article-title":"Topical curcumin for the prevention of oral mucositis in pediatric patients: Case series","volume":"19","author":"Elad","year":"2013","journal-title":"Altern Ther Health Med"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_1017_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:38:14Z","timestamp":1787067494000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_1017_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_1017_20","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"2020-07-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}